Closing Bell: Appili Therapeutics Inc down on Monday (APLI)
Today in trading, Appili Therapeutics Inc shares closed at $0.03 after opening the day at $0.03. prices ranged from a low of $0.03 to a high of $0.03.
Share prices plummeted -25.00% from the previous day's close of $0.04.
During the day across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.
Appili Therapeutics Inc traded under APLI on the Toronto Stock Exchange (TSX).
A total of 1,000 shares was traded during the last trading day, with total trades of 1, while having an average volume of 17,801 in the last five days.
Trading across the entire TSX saw 1,903 price advancers against 3,356 declines and 91 unchanged.
During the prior 52 weeks, APLI.TO has traded as high as $0.08 (September 25,2023) and low as $0.03 (March 27,2024). Moreover, the shares have shrunken -45.45% in the last 12 months, while in 2024, they have eased -14.29%.
Following today's trading, Appili Therapeutics Inc has a market capitalization of $4.85 million on a float of 121,266 shares outstanding. Its annual EPS is $-0.03.
Appili Therapeutics Inc is a None company headquartered in Halifax, CAN.
Currently, Appili Therapeutics Inc's consensus rating is "Hold" based on 1 analysts according to Zacks. From those 1 analysts, 1 analysts gave hold ratings.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
